Whole genome sequencing of low input circulating cell‐free DNA obtained from normal human subjects. Issue 15 (4th August 2021)

• Record Type: Journal Article
• Authors: Foley, Julie F.; Elgart, Brian; Alex Merrick, B.; Phadke, Dhiral P.; Cook, Molly E.; Malphurs, Jason A.; Solomon, Gregory G.; Shah, Ruchir R.; Fessler, Michael B.; Miller, Frederick W.; Gerrish, Kevin E.
• Is Part Of: Physiological reports. Volume 9:Issue 15(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-08-04
• Subjects: circulating cell‐free DNA -- genomic sequencing -- plasma DNA -- variants; Physiology -- Periodicals; 571
• DOI: 10.14814/phy2.14993
• Languages: English
• ISSNs: 2051-817X

Abstract

Abstract: Cell‐free DNA circulates in plasma at low levels as a normal by‐product of cellular apoptosis. Multiple clinical pathologies, as well as environmental stressors can lead to increased circulating cell‐free DNA (ccfDNA) levels. Plasma DNA studies frequently employ targeted amplicon deep sequencing platforms due to limited concentrations (ng/ml) of ccfDNA in the blood. Here, we report whole genome sequencing (WGS) and read distribution across chromosomes of ccfDNA extracted from two human plasma samples from normal, healthy subjects, representative of limited clinical samples at <1 ml. Amplification was sufficiently robust with ~90% of the reference genome (GRCh38.p2) exhibiting 10X coverage. Chromosome read coverage was uniform and directly proportional to the number of reads for each chromosome across both samples. Almost 99% of the identified genomic sequence variants were known annotated dbSNP variants in the hg38 reference genome. A high prevalence of C>T and T>C mutations was present along with a strong concordance of variants shared between the germline genome databases; gnomAD (81.1%) and the 1000 Genome Project (93.6%). This study demonstrates isolation and amplification procedures from low input ccfDNA samples that can detect sequence variants across the whole genome from amplified human plasma ccfDNA that can translate to multiple clinical research disciplines. Abstract : Plasma DNA studies frequently employ targeted amplicon deep sequencing platforms due to limited concentrations (ng/ml) of ccfDNA in the blood. This study demonstrates isolation and amplification procedures from low input ccfDNA samples that can detect sequence variants across the whole genome from amplified human plasma ccfDNA that can translate to multiple clinical research disciplines.